Variant Bio

Developer of therapeutics for the treatment of orphan indications

placeBrooklyn, New York, United States calendar_todayFounded 2018 groups50 employees language variantbio.com

Social engagement

Social engagement: 6.2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Lux Capital.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%
Coming soon